Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

The document provides a method to classify human hair growth stages using a model with human scalp on mice, aiming to standardize hair research.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Hair loss causes stress and affects mental health; treatment and support needed.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

The conclusion is that recognizing hair growth cycles can improve the precision of dietary and health assessments from hair analysis.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Doctors need to be better prepared to assess and treat obesity in patients.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Melatonin improves cashmere goat hair growth and quality by increasing antioxidants and reducing cell death.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.